晚期卵巢癌中间型减瘤术微创可行性的腹腔镜预测:MIID-SOC 试验
多机构前瞻性先导研究纳入50例接受新辅助化疗的晚期上皮性卵巢癌患者,腹腔镜评估43个腹盆腔部位后由术者决定继续微创或开腹,微创组加用手助端口行手动触诊并重新评估43个部位。
要点
- 50例接受新辅助化疗的晚期上皮性卵巢癌患者中,27例(61%)行微创手术。
- PIV<2预测可完成最佳微创减瘤术的准确率为68.2%,特异度为66.7%。
核心结论
- 该预测指数模型可能有助于指导未来评估微创途径的随机研究的纳入标准。
研究设计与样本
- 多机构前瞻性先导研究(NCT03378128),共纳入50例接受新辅助化疗的晚期上皮性卵巢癌女性。
- 每例患者先行腹腔镜评估43个腹盆腔部位,再由术者决定继续微创或开腹;若继续微创,则强制放置手助端口行手动触诊以模拟开腹途径,并重新评估全部43个部位。
主要发现
- 27例患者(61%)行微创手术。
- 最终模型纳入的腹盆腔部位为:胃脾韧带、直肠、左结肠系膜、横结肠、右结肠、盲肠、阑尾、肝包膜、肝内窝/胆囊、回肠/空肠。
- 基于预测指数评分(PIV)生成的ROC曲线AUC=0.695。
- 最终模型中,PIV<2识别可完成最佳微创减瘤术患者的准确率为68.2%。
- 特异度(识别无法完成最佳微创中间型减瘤术患者的能力)为66.7%。
关键数值与推荐
- 对每个部位计算灵敏度、特异度、阳性预测值、阴性预测值和总体准确率以预测微创可切除性。
- 根据统计关联强度为每个参数赋值,并为每例患者计算总预测指数评分(PIV)。
- 采用受试者工作特征曲线分析评估模型预测微创途径的能力。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We sought to create a laparoscopic-based model to predict the ability to perform a minimally invasive (MIS) cytoreductive surgery in advanced epithelial ovarian cancer patients who have received neoadjuvant chemotherapy (NACT). METHODS: Fifty women were enrolled in a multi-institutional prospective pilot study (NCT03378128). Each patient underwent laparoscopic evaluation of 43 abdominopelvic sites followed by surgeon dictated surgical approach, either continue MIS or laparotomically. However, if the procedure continued MIS, the placement of a hand-assist port for manual palpation was mandated to emulate a laparotomic approach and all 43 sites were re-evaluated. Sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy were calculated for each site to predict MIS resectability. Each parameter was assigned a numeric value based on the strength of statistical association and a total predictive index score (PIV) was assigned for each patient. Receiver operating characteristic curve analysis was used to assess the ability of the model to predict the MIS approach. RESULTS: Twenty-seven patients (61%) underwent MIS surgery. The following abdominopelvic sites were selected for inclusion in the model: gastrosplenic ligament, rectum, left mesocolon, transverse colon, right colon, cecum, appendix, liver capsule, intrahepatic fossa/gallbladder, ileum/jejunum. Using the PIV, a ROC was generated with an AUC = 0.695. In the final model, a PIV <2 identified patients able to undergo an optimal MIS cytoreductive surgery with an accuracy of 68.2%. The specificity, or the ability to identify patients who would not be able to undergo an optimal MIS interval cytoreductive surgery, was 66.7%. CONCLUSION: This predictive index model may help to guide future inclusion criteria in randomized studies evaluating the MIS approach in advanced epithelial ovarian cancer.
引用
- Costales AB, Crane EK, Chambers L, et al. Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial. Gynecol Oncol. 2024. PMID: 38417209. doi:10.1016/j.ygyno.2024.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。